AlphAIAlphAI — Financial news for AI agents
fool.comSEP 92 min read$PHR

Why Phreesia Stock Got Knocked Down Today

Phreesia (PHR) stock fell 7% Tuesday due to bearish sentiment after Q2 earnings and a downgrade by Raymond James analyst John Ransom. Ransom cited declining organic revenue growth and AI spending pressures. Despite a 10% revenue increase, concerns remain about future performance and market constraints.

Original reporting
fool.com
Published Sep 9, 2026, 1:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 1:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Why Phreesia Stock Got Knocked Down Today — source image
Source · fool.com
Decision brief

The 30-second read

$PHRBearishMed
01

Why it matters

The downgrade amplified the price decline, highlighting short‑term risk for traders.

02

Market read

The stock's near‑7% drop underscores immediate downside pressure for investors.

03

What to watch

Recent 10% YoY revenue growth and tripling of profitability suggest underlying resilience.

Relevance 7/10Novelty 7/10Timing: pre‑market Tuesday

Background

Phreesia reported Q2 results with revenue up 10% YoY but missed earnings expectations; analysts flagged declining organic growth and AI spend.

Company-level read

Ticker impact

$PHRBearishMedium confidence
Context

Phreesia stock fell ~7% after Raymond James downgraded the rating to market perform following its Q2 earnings.

Expected impact

Further downside risk if revenue growth remains weak.

Evidence & confidence

Analyst downgrade combined with earnings miss often leads to continued selling pressure.

Market effects

Sector

Healthcare software peers may see heightened scrutiny on AI spend and revenue growth.

Regional

U.S. small‑cap tech sector could face modest pullback.

Global

Limited to U.S. listed health‑tech stocks.

Counterpoint

What could challenge this read

If the AI investment yields long‑term margin expansion, the stock could rebound on future earnings.

Key entities

  • Analyst
    Raymond James

    Downgraded Phreesia to market perform.

Read at source← All news

Related articles

SEP 13
$PHRMed

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Phreesia (PHR) reported Q2 2027 revenue of $129.5M and adjusted EBITDA of $32.9M, marking five straight quarters of positive net income. Revenue grew 10% YoY, with client count and revenue per client also increasing. The company reduced debt by $23M and credited AI for operational efficiencies. However, management warned of increased unpredictability in network solutions revenue due to financial strain on healthcare providers. Phreesia reaffirmed its full-year revenue and EBITDA guidance.

insidermonkey.com3 min
SEP 9
$PHRHighAI 8/10

Phreesia (PHR) Q2 2027 Earnings Call Transcript

Phreesia (PHR) reported Q2 2027 revenue of $129.5M, up 10% YoY, with adjusted EBITDA of $32.9M and net income of $1.9M. AHSCs grew 6% to 4,744. Full-year guidance: revenue $510M-$520M, adjusted EBITDA $125M-$135M. Management noted variability in revenue forecasting and economic pressures on healthcare providers.

fool.com2 min
SEP 4
$PHRMed

Why Phreesia Stock Tumbled Today

Phreesia (PHR) shares fell 6.33% after reporting Q2 2027 revenue of $129.5M, up 10% YoY, and GAAP net income of $1.9M. While revenue beat estimates, earnings per share missed expectations. The company maintained full-year guidance and highlighted recent product launches.

fool.com2 min
SEP 2
$PHRLow

Phreesia Announces Second Quarter Fiscal 2027 Results

Phreesia, Inc. (PHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Phreesia Announces Second Quarter Fiscal 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del., September 2, 2026 – Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia deli

SEC EDGAR 8-K2 min
OCT 3
$VSTMedAI 8/10

US plans $4bn nuclear loan for Vistra, reports say

The US government reportedly plans to lend Vistra Corp. (VST) $4bn-$4.2bn to upgrade nuclear plants, according to Bloomberg and Reuters. VST shares rose 4.93% on 2 October 2026. Neither the Department of Energy nor VST has confirmed the loan. VST's recent earnings show volatility but overall improvement.

financial-news.co.uk2 min